Treatment of thromboembolism in cancer patients

Expert Opinion on Pharmacotherapy
Marina Panova-Noeva, Anna Falanga

Abstract

Cancer patients are at increased risk of developing venous thromboembolism (VTE). The occurrence of VTE predicts worse prognosis in cancer patients: whereas the 1-year survival in cancer patients free of thrombosis is 36%, in patients with diagnosed VTE it is 12%. The management of VTE in cancer patients is challenging because the anticoagulant treatment in these patients can be less effective and carry considerable morbidity. This review covers the treatment strategies for cancer patients with VTE and highlights the new anticoagulant agents and their potential use in oncology. In writing this review, a literature search was performed using the PUB MED database with the following subject headings: cancer, venous thromboembolism and anticoagulant treatment. A comprehensive overview of the current recommendations for prevention and treatment of VTE in cancer patients. In addition, this review provides an insight into the new anticoagulant drugs potentially suitable for use in oncology, in particular idraparinux, apixaban, rivaroxaban and dabigatran etexilate. Low-molecular-weight heparin remains the best treatment option for initial and long term treatment of VTE in cancer patients.

References

Mar 29, 2000·Archives of Internal Medicine·P O HanssonH Eriksson
Dec 16, 2000·The New England Journal of Medicine·H T SørensenJ A Baron
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J LittlewoodUNKNOWN Epoetin Alfa Study Group
Jun 1, 2002·Archives of Internal Medicine·John A HeitL Joseph Melton
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Oct 31, 2003·The New England Journal of Medicine·H R BüllerUNKNOWN Matisse Investigators
Jun 3, 2004·Annals of Internal Medicine·Harry R BüllerUNKNOWN Matisse Investigators
Sep 24, 2004·Cancer·Michael J WallaceMarshall E Hicks
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jeanet W BlomFrits R Rosendaal
Aug 12, 2005·Current Opinion in Pulmonary Medicine·Anna Falanga, Andrea Piccioli
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alok A KhoranaGary H Lyman
Feb 8, 2006·Journal of Thrombosis and Haemostasis : JTH·J W BlomF R Rosendaal
Mar 1, 2006·Archives of Internal Medicine·Helen K ChewRichard H White
Mar 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison AlcalayRichard H White
Jul 14, 2006·Critical Reviews in Oncology/hematology·M MandalàUNKNOWN working group AIOM
Sep 9, 2006·Vascular and Endovascular Surgery·Christian SchunnUsman Waheed
Oct 6, 2006·Journal of the National Comprehensive Cancer Network : JNCCN·Lawrence D WagmanUNKNOWN National Comprehensive Cancer Network
Nov 1, 2006·Critical Reviews in Oncology/hematology·T M H NiersD J Richel
Apr 6, 2007·Gynecologic Oncology·Anne O RodriguezRichard H White
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·H R BullerP W Kamphuisen
Sep 15, 2007·The New England Journal of Medicine·UNKNOWN van Gogh InvestigatorsGary E Raskob
Sep 15, 2007·The New England Journal of Medicine·UNKNOWN van Gogh InvestigatorsGary E Raskob
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Dec 21, 2007·Leukemia·A PalumboUNKNOWN International Myeloma Working Group
Jan 1, 2008·Archives of Medical Research·Salam AlkindiAnil Pathare
Feb 21, 2008·Journal of Thrombosis and Haemostasis : JTH·S IodiceP Maisonneuve
May 9, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MandalàUNKNOWN ESMO Guidelines Working Group

❮ Previous
Next ❯

Citations

Jan 19, 2011·Current Treatment Options in Cardiovascular Medicine·Andrea Piccioli, Paolo Prandoni
Apr 7, 2011·Vascular Health and Risk Management·Shozo Yasuoka, Shunichiro Kubota
Jan 3, 2013·Journal of Thrombosis and Haemostasis : JTH·A FalangaA Vignoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.